Skip to main content

MES 375 (Mesalamine Extended-Release 375 mg)

Pill with imprint MES 375 is Blue, Capsule-shape and has been identified as Mesalamine Extended-Release 375 mg. It is supplied by Ascend Laboratories, LLC.

Mesalamine is used in the treatment of crohn's disease, maintenance; inflammatory bowel disease; ulcerative colitis; ulcerative proctitis; ulcerative colitis, maintenance and belongs to the drug class 5-aminosalicylates. excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 375 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MES 375

Mesalamine Extended-Release

MES 375
375 mg
Prescription only
Drug Class
Pregnancy Category
B - No proven risk in humans - excluding Asacol and Asacol HD, C - Risk cannot be ruled out - Asacol and Asacol HD
CSA Schedule
Not a controlled drug
Labeler / Supplier
Ascend Laboratories, LLC
Alkem Laboratories Limited
National Drug Code (NDC)
Inactive Ingredients
microcrystalline cellulose, hypromellose 2208 (4000 mPa.s), silicon dioxide, magnesium stearate, ethyl acrylate - methyl methacrylate copolymer, methacrylic acid - methyl methacrylate copolymer (1:1), talc, triethyl citrate, hypromellose 2910 (5 mPa.s), titanium dioxide, polyethylene glycol 400, vanillin, gelatin, FD&C Blue No. 1, FD&C Red No. 3, shellac, ferrosoferric oxide, sodium lauryl sulfate, nonoxynol-100

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.